Day: December 16, 2020

Not for distribution to United States newswire services or for dissemination in the United StatesMONTREAL, Dec. 16, 2020 (GLOBE NEWSWIRE) — SIRIOS INC. RESOURCES (TSX-V: SOI) (the “Corporation“) is pleased to announce the completion of the second and final tranche of its previously announced non-brokered private placement, for additional gross proceeds of $2,045,200 (the “Offering”). The aggregate gross proceeds of the offering, including proceeds from the first tranche, previously closed on December 11, 2020, are $3,430,590. In connection with this Offering, the Corporation issued (i) 7,395,556 additional Quebec flow-through units of the Corporation (the “Quebec FT Units”) at a price of $0.18 per Quebec FT Unit, for an amount of $1,331,200, and (ii) 4,200,000 additional national flow-through units of the Corporation (the “National...

Le présent communiqué ne doit pas être distribué aux agences de diffusion de communiqués de presse des États-Unis ni diffusé aux États-Unis                                                           MONTRÉAL, 16 déc. 2020 (GLOBE NEWSWIRE) — RESSOURCES SIRIOS INC. (TSX-V: SOI) (la « Société ») annonce aujourd’hui la clôture de la deuxième et dernière tranche de son placement privé sans l’entremise d’un courtier annoncé précédemment, pour un montant additionnel de 2 045 200 $ (le « Placement »). Le produit brut total du placement, incluant le produit de la première tranche précédemment clôturée le 11 décembre 2020, est de 3 430 590 $. Le Placement consiste en l’émission de (i) 7 395 556 unités accréditives du Québec additionnelles (les « Unités accréditives du Québec ») au prix de 0,18 $ par Unité accréditive du Québec pour un montant...

FAIRFIELD, Conn., Dec. 16, 2020 (GLOBE NEWSWIRE) — Acme United Corporation (NYSE American: ACU) today announced that it has acquired the assets of Med-Nap LLC., a leading manufacturer of alcohol prep pads, alcohol wipes, benzalkonium chloride wipes (BZK), antiseptic wipes, castile soap, and lens cleaning products.Med-Nap has estimated revenues in 2020 of approximately $4.9 million and EBITDA of approximately $1.0 million. The purchase price was not disclosed. The acquisition is expected to be accretive commencing in the first quarter of 2021. The company, based in Brooksville, Florida, was founded in 2007 and employs 25 people.Walter C. Johnsen, Chairman and CEO, said, “The acquisition of Med-Nap’s business provides our company with an FDA-registered manufacturing facility in the U.S. for antiseptic wipes and pads that are used in...

CALGARY, Alberta, Dec. 16, 2020 (GLOBE NEWSWIRE) — Middlefield Group is pleased to announce that the Sustainable Infrastructure Dividend Fund (“the Fund”) (TSX: INF.UN) has made an initial capital commitment to Brookfield Super-Core Infrastructure Partners L.P. (“Brookfield L.P.”).The Fund is focused on sustainable, long-life infrastructure providing essential services to society across both public and private markets. The initial capital commitment of approximately US$5,000,000 to Brookfield Super-Core Infrastructure Partners L.P. will provide direct access to a portfolio of private, core infrastructure assets primarily located in North America, Europe and Australia. The Brookfield L.P. has traditionally been available to select large, institutional investors. Brookfield is an alternative asset manager with over $575 billion in...

SAN DIEGO, Dec. 16, 2020 (GLOBE NEWSWIRE) — NEOVOLTA INC. (OTCQB: NEOV) – Nevada Energy, the state’s largest utility, has officially approved NeoVolta smart energy storage systems for grid operations. The utility serves more than 1.4 million customers throughout the state, as well as some 50 million tourists each year. NeoVolta systems are now being installed near Las Vegas in the Henderson area.Nevada is one of the leading states for solar energy, currently ranking sixth in total capacity. NeoVolta’s expansion there comes through an exclusive distribution agreement recently signed with PMP Energy. In exchange for making minimum purchases of up to $15 million, PMP Energy is able to secure specific geographic exclusivities for distribution over the three-year term of the agreement. Under the agreement, PMP Energy provides dealers...

CINCINNATI, Dec. 16, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it has been awarded funding in the amount of approximately $1M by the National Institute of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative, to expedite the launch of the company’s SARS-CoV-2 molecular diagnostic test on the Revogene® platform. On December 7, the application for Emergency Use Authorization (EUA) for the Revogene® SARS-CoV-2 assay was submitted to the U.S. Food and Drug Administration (FDA).NIH funds were critical to support the development of a new assay consumable for the Revogene® platform enabling the detection of RNA targets, such as SARS-CoV-2 genomic RNA, directly from viral transport media without pre-dilution...

Ferratum Oyj Board of Directors approves a plan to convert Ferratum Oyj to a European Company (SE)Helsinki, 16 December 2020 – Ferratum Oyj (ISIN: FI4000106299, WKN: A1W9NS) (“Ferratum” or “the Group”) announced on 29 October 2020 that it contemplates conversion into a European Company (Societas Europae, SE) (the “Conversion”).The Board of Directors of Ferratum have today resolved to approve the draft terms of Conversion and a report explaining and justifying the legal and economic aspects of the Conversion. The Conversion will be carried out to emphasize the international reach of the Group’s operations and strengthen Ferratum’s European identity. The aim is to make the Group structure more transparent and leaner from a governance perspective. The Conversion will be carried out in accordance with the Finnish Act on European Company (742/2004)...

TORONTO, Dec. 16, 2020 (GLOBE NEWSWIRE) — Allied Properties Real Estate Investment Trust (“Allied”)(TSX:AP.UN) will hold a conference call and live audio webcast at 10:00 a.m. (ET) on Thursday, February 4, 2021, to discuss financial results for the quarter ended December 31, 2020. The financial results will be released on Wednesday, February 3, 2021, after the markets close.The conference call can be accessed by dialing 1(866)248-8441 or (647)792-1240. The webcast will be accessible at www.alliedreit.com and will be archived for 90 days.Allied is a leading owner, manager and developer of (i) distinctive urban workspace in Canada’s major cities and (ii) network-dense urban data centres in Toronto that form Canada’s hub for global connectivity. Allied’s business is providing knowledge-based organizations with distinctive urban environments...

COPENHAGEN, Denmark, December 16, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the U.S. Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, has exercised an option covering the majority of the second year of performance under the USD $200 million order for JYNNEOS® (Smallpox and Monkeypox Vaccine, Live, Non-replicating) awarded in April 2020.The first USD $106 million covered both manufacturing of bulk vaccine and supply of liquid-frozen JYNNEOS doses and was secured upon contract award last April. With the current option, BARDA is committing to an additional USD $83 million for the procurement of more bulk smallpox vaccine, which will be manufactured and invoiced in 2021....

KØBENHAVN, Danmark, 16. december 2020 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at Biomedical Advanced Research and Development Authority (BARDA), en del af Office of the Assistant Secretary for Preparedness and Response ved U.S. Department of Health and Human Services, har udnyttet en option, der dækker hovedparten af det andet år af kontrakten på USD 200 mio. på JYNNEOS® (Smallpox and Monkeypox Vaccine, Live, Non-replicating), som blev tildelt i april 2020.De første USD 106 mio., der dækker både produktion af bulkvaccine samt levering af flydende-frossen JYNNEOS, blev sikret ved indgåelse af kontrakten i april. Med optionen tilkøber BARDA for yderligere USD 83 mio. bulkvaccine, som vil blive produceret og faktureret i 2021. Den resterende option på USD 12 mio. dækker levering af flere færdigproducerede doser af flydende-frossen...